| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 141,506 | 143,133 | 121,703 | | Cost of Revenue | 35,139 | 88,039 | 44,388 | | | Gross Profit | 106,367 | 55,094 | 77,315 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 57,450 |
-
| 24,119 | | Non Recurring |
-
|
-
| (989) | | Others | 17,829 | 19,671 | 17,980 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 31,088 | 35,423 | 36,205 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,594 | 502 | (4,095) | | Earnings Before Interest And Taxes | 43,682 | 35,925 | 32,110 | | Interest Expense | 16,183 | 20,062 | 16,397 | | Income Before Tax | 27,499 | 15,863 | 15,713 | | Income Tax Expense | 8,904 | 8,532 | 6,944 | | Minority Interest | (687) | (644) | (753) | | | | Net Income From Continuing Ops | 22,404 | 10,035 | 8,016 | | | Non-recurring Events | | Discontinued Operations | (88) | 1,402 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 22,316 | 11,437 | 8,016 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,316 | $11,437 | $8,016 |
|
0.18% Nasdaq 
0.42%
Income Statement
